Chief Physician, Deputy Director of the Department of Oncology, Shenzhen Longhua District Central Hospital. He currently holds multiple academic positions, including Chairman of the Oncology Committee of Longhua District Medical Association; Member of the Oncology Committee of Shenzhen Medical Association; Member of the Cancer Rehabilitation and Palliative Care Committee of Shenzhen Anti-Cancer Association; Member of the Oncology Committee of Shenzhen Health Management Association; Member of the Immunotherapy Branch of Guangdong Health Care Association; Member of the Melanoma Committee of Guangdong Anti-Cancer Association; and Member of the Oncology Committee of Guangdong Medical Education Association.

He obtained his Doctorate in Oncology from Wuhan University in 2009. He served as Deputy Director of the Oncology Department at a prefecture-level tertiary hospital for more than ten years. He received advanced training and academic visiting at Union Cancer Center of Huazhong University of Science and Technology, Sun Yat-sen University Cancer Center, and San Luigi Hospital in Italy. In 2018, he was recruited by our hospital as a Class E High-Level Medical Talent of Longhua District, Shenzhen.

He has presided over 2 provincial and department-level scientific research projects and participated in a number of national research projects. He has published more than 10 academic papers at home and abroad. He has repeatedly received outstanding staff honors in the hospital and maintains a high patient satisfaction rate.

With over 20 years of clinical experience in tumor radiotherapy and chemotherapy, he has extensive expertise in the diagnosis and treatment of common malignant tumors. He specializes in the comprehensive treatment and whole-course management of breast cancer, lung cancer, gastric cancer, colorectal cancer, ovarian cancer and prostate cancer. He is particularly proficient in gene testing-guided immunotherapy, molecular targeted therapy and chemotherapy, as well as puncture biopsy and radiofrequency ablation for thoracic and abdominal tumors.

Scope of Diagnosis and Treatment: Medical treatment of malignant solid tumors, including breast cancer, lung cancer, esophageal cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer, cholangiocarcinoma, ovarian cancer, cervical cancer, endometrial cancer, prostate cancer, nasopharyngeal carcinoma and other head and neck tumors, soft tissue tumors, and gastrointestinal stromal tumors.